Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct
- PMID: 15507472
- DOI: 10.1096/fj.04-2178fje
Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct
Abstract
Recent interest in the annexin 1 field has come from the notion that specific G-protein-coupled receptors, members of the formyl-peptide receptor (FPR) family, appear to mediate the anti-inflammatory actions of this endogenous mediator. Administration of the annexin 1 N-terminal derived peptide Ac2-26 to mice after 25 min ischemia significantly attenuated the extent of acute myocardial injury as assessed 60 min postreperfusion. Evident at the dose of 1 mg/kg (approximately 9 nmol per animal), peptide Ac2-26 cardioprotection was intact in FPR null mice. Similarly, peptide Ac2-26 inhibition of specific markers of heart injury (specifically myeloperoxidase activity, CXC chemokine KC contents, and endogenous annexin 1 protein expression) was virtually identical in heart samples collected from wild-type and FPR null mice. Mouse myocardium expressed the mRNA for FPR and the structurally related lipoxin A4 receptor, termed ALX; thus, comparable equimolar doses of two ALX agonists (W peptide and a stable lipoxin A4 analog) exerted cardioprotection in wild-type and FPR null mice to an equal extent. Curiously, marked (>95%) blood neutropenia produced by an anti-mouse neutrophil serum did not modify the extent of acute heart injury, whereas it prevented the protection afforded by peptide Ac2-26. Thus, this study sheds light on the receptor mechanism(s) mediating annexin 1-induced cardioprotection and shows a pivotal role for ALX and circulating neutrophil, whereas it excludes any functional involvement of mouse FPR. These mechanistic data can help in developing novel therapeutics for acute cardioprotection.
Similar articles
-
Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action.FASEB J. 2001 Oct;15(12):2247-56. doi: 10.1096/fj.01-0196com. FASEB J. 2001. PMID: 11641252
-
Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.Blood. 2003 May 15;101(10):4140-7. doi: 10.1182/blood-2002-11-3411. Epub 2003 Jan 30. Blood. 2003. PMID: 12560218
-
Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.J Immunol. 2013 Jun 15;190(12):6478-87. doi: 10.4049/jimmunol.1203000. Epub 2013 May 17. J Immunol. 2013. PMID: 23686496
-
Cardioprotective potential of annexin-A1 mimetics in myocardial infarction.Pharmacol Ther. 2015 Apr;148:47-65. doi: 10.1016/j.pharmthera.2014.11.012. Epub 2014 Nov 25. Pharmacol Ther. 2015. PMID: 25460034 Review.
-
Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.J Leukoc Biol. 2008 Sep;84(3):600-6. doi: 10.1189/jlb.1107765. Epub 2008 May 21. J Leukoc Biol. 2008. PMID: 18495783 Review.
Cited by
-
Annexin A1 regulates intestinal mucosal injury, inflammation, and repair.J Immunol. 2008 Oct 1;181(7):5035-44. doi: 10.4049/jimmunol.181.7.5035. J Immunol. 2008. PMID: 18802107 Free PMC article.
-
The advantageous role of annexin A1 in cardiovascular disease.Cell Adh Migr. 2017 May 4;11(3):261-274. doi: 10.1080/19336918.2016.1259059. Epub 2016 Nov 18. Cell Adh Migr. 2017. PMID: 27860536 Free PMC article. Review.
-
Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression.Life (Basel). 2021 Mar 15;11(3):243. doi: 10.3390/life11030243. Life (Basel). 2021. PMID: 33804219 Free PMC article. Review.
-
Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation.J Immunol. 2010 Mar 1;184(5):2611-2619. doi: 10.4049/jimmunol.0903526. Epub 2010 Jan 27. J Immunol. 2010. PMID: 20107188 Free PMC article.
-
G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis.Front Pharmacol. 2019 May 22;10:531. doi: 10.3389/fphar.2019.00531. eCollection 2019. Front Pharmacol. 2019. PMID: 31191301 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials